Developer of medical robotic devices designed to diagnose and treat patients across multiple indications.
Developer of medical robotic devices designed to diagnose and treat patients across multiple indications.
Diagnostic Equipment📍 San Carlos, CAFounded 2018
Current Valuation
$2.0B
as of 2025-Q3
UNICORN
QL Price
$1.4B
-32% vs last round
QuantLogix's current estimate for Noah Medical, published 2026-09-08 — below the last disclosed round of $2.0B (2025-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$2.0B
2025-Q3
weight 0.52
Secondary market print
$844M
2026-06-27
weight 0.64
How this price has held up
No round has priced for Noah Medical since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-08 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Noah Medical, 2026-09-08 (e84f59b2757cbf29).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Noah Medical going public?
No. Noah Medical is private and has not filed to go public. There is no S-1 on file.
What is Noah Medical's valuation in 2026?
Noah Medical is valued at $2.0B as of 2025-Q3, set by its Series B1 ($230M, Sep 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Noah Medical filed an S-1?
No public S-1 is on file for Noah Medical.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2018
HQ
San Carlos, CA
Employees
315
Total Raised
$516.8M
Last Round
Series B1 — $230M (Sep 2025)
IPO Status
private
Fundraising Status
Series B1 · $230M · 1y ago
privateTotal raised $516.8M
Secondary Market
Implied price / share
$5
Last round price / share
$11.84
vs last round
-57.8%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series B1
$230M
Sep 2025
—
$2.0B
Talent Signal
Hiring trend
▶ Hiring steady
29% of roles posted in last 30d
Open roles
17
via greenhouse
Product-build share
59%
engineering, research, product, design
Trajectory
steady
product-led hiring — 59% of open roles build product; the rest are go-to-market and G&A.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Clinical Specialist - Charlotte Clinical Specialist - South Carolina Manufacturing System Test Technician Principal Product ManagerSr. Clinical EngineerSr. Equipment Automation Engineer (Software)
Counted from Noah Medical's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareHealth DiagnosticsMedical Device
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q3. Refreshed quarterly.